Sollazon

Medicinal product

(Invented) name

Sollazon

Active substance (s)

Cilostazolas

Strength

100 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

B01AC23, Cilostazol

Marketing authorisation holder

UAB Limedika, Lietuva

Date of authorisation

2020-06-16

Date of renewal

Documents

1309_Sollazon_100mg_tab_PZPL_2020-06-16.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

tabletėje yra	1 vnt.
Cilostazolas	100 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
104514	90618	1090618	lizdinė plokštelė	N56		Receptinis	LT/L/20/1309/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2020-06-16	Registruotas